Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer

American Journal of Clinical Pathology

Volumn 119, Issue 3, 2003, Pages 392-402

  Evans, James D ^a   Cornford, Philip A ^a   Dodson, Andrew ^a   Neoptolemos, John P ^a   Foster, Christopher S ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Pancreatic diseases; Protein kinase C isoenzymes; Signaling pathways

Indexed keywords

ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C GAMMA; PROTEIN KINASE C IOTA; PROTEIN KINASE C MU; PROTEIN KINASE C THETA; PROTEIN KINASE C ZETA; RECEPTOR; RECEPTOR FOR ACTIVATED C KINASE 1; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; RECEPTORS FOR ACTIVATED C KINASE;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS CARCINOMA; PANCREAS DUCT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STROMA; TISSUE SPECIFICITY; VATER PAPILLA CARCINOMA; CHRONIC DISEASE; CLASSIFICATION; ENZYME IMMUNOASSAY; ENZYMOLOGY; HISTOLOGY; METABOLISM; PANCREAS; PANCREAS TUMOR; PANCREATITIS; PATHOLOGY;

CARCINOMA, PANCREATIC DUCTAL; CHRONIC DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS; PROTEIN KINASE C; RECEPTORS, CELL SURFACE;

EID: 0037362895     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/BKPC9DX98R781B87     Document Type: Article

References (61)

1. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J. 1998;332:281-292.
2. Lord JM, Pongracz J. Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis. Mol Pathol. 1995;48:57-64.
3. Silei V, Politi V, Lauro GM. Uridine induces differentiation in human neuroblastoma cells via protein kinase C epsilon. J Neurosci Res. 2000;61:206-211.
4. Freed E, Gailit J, van der Geer P, et al. A novel integrin beta subunit is associated with the vitronectin receptor alpha subunit (alpha v) in a human osteosarcoma cell line and is a substrate for protein kinase C. EMBO J. 1989;8:2955-2965.
5. 2+-phospholipid-dependent protein kinase in rat islets and hamster beta-cells. Biochem J. 1984;219:547-551.
6. Owen PJ, Johnson GD, Lord JM. Protein kinase C-delta associates with vimentin intermediate filaments in differentiated HL60 cells. Exp Cell Res. 1996;225:366-373.
7. Berry N, Nishizuka Y. Protein kinase C and T cell activation. Eur J Biochem. 1990;189:205-214.
8. Cross T, Griffiths G, Deacon E, et al. PKC-delta is an apoptotic lamin kinase. Oncogene. 2000;19:2331-2337.
9. Dekker LV, Parker PJ. Protein kinase C: a question of specificity. Trends Biochem Sci. 1994;19:73-77.
10. Lemoine NR. The molecular pathology of pancreatic cancer. In: Beger HG, Buchler M, Malfertheiner P, eds. Standards in Pancreatic Surgery. Berlin, Germany: Springer Verlag; 1993:573-577.
11. Rodriguez-Martin E, Boyano-Adanez MC, Bodega G, et al. Redistribution of protein kinase C isoforms in rat pancreatic acini during lactation and weaning. FEBS Lett. 1999;445:356-360.
12. Martelli AM, Sang N, Borgatti P, et al. Multiple biological responses activated by nuclear protein kinase C. J Cell Biochem. 1999;74:499-521.
13. Csukai M, Mochly-Rosen D. Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation. Pharmacol Res. 1999;39:253-259.
14. Jaken S. Protein kinase C isozymes and substrates. Curr Opin Cell Biol. 1996;8:168-173.
15. Schechtman D, Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene. 2001;20:6339-6347.
16. Staudinger J, Zhou J, Burgess R, et al. PICK-1: a perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system. J Cell Biol. 1995;128:263-271.
17. Stepan VM, Tatewaki M, Matsushima M, et al. Gastrin induces c-fos gene transcription via multiple signaling pathways. Am J Physiol. 1999;276(2 pt 1):G415-G424.
18. Way KJ, Chou E, King GL. Identification of PKC-isoformspecific biological actions using pharmacological approaches. Trends Pharmacol Sci. 2000;21:181-187.
19. Kiley SC, Schaap D, Parker P, et al. Protein kinase C heterogeneity in GH4C1 rat pituitary cells. J Biol Chem. 1990;265:15704-15712.
20. Mochley-Rosen D. Localisation of protein kinases by anchoring proteins: a theme in signal transduction. Science. 1995;268:247-251.
21. Huang KP, Huang FL. Conversion of protein kinase C from a calcium-dependent to an independent form of phorbol ester binding protein by digestion with trypsin. Biochem Biophys Res Commun. 1986;139:320-326.
22. Kiley SC, Clark KJ, Duddy SK, et al. Increased protein kinase C delta in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene. 1999;18:6748-6757.
23. Wang XY, Repasky E, Liu HT. Antisense inhibition of protein kinase C alpha reverses the transformed phenotype in human lung carcinoma cells. Exp Cell Res. 1999;25:253-263.
24. Kuranami M, Powell CT, Hug H, et al. Differential expression of protein kinase C isoforms in human colorectal cancers. J Surg Res. 1995;58:233-239.
25. Leszczynski D, Joenvaara S, Foegh ML. Apoptosis of rat vascular smooth muscle cells is regulated by delta and zeta but not alpha and epsilon isoforms of protein kinase C [abstract]. Mol Biol Cell. 1995;6:246a.
26. Kiley SC, Clark KJ, Goodnough M, et al. Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Res. 1999;59:3230-3238.
27. Chambers TC, McAvoy EM, Jacobs JW, et al. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem. 1990;265:7679-7686.
28. Sachs CW, Chambers TC, Fine RL. Differential phosphorylation of sites in the linker region of P-glycoprotein by protein kinase C isozymes alpha, betaI, betaII, gamma, delta, epsilon, eta, and zeta. Biochem Pharmacol. 1999;58:1587-1592.
29. Comford PA, Evans JD, Dodson AR, et al. Protein kinase C (PKC) isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol. 1999;154:137-144.
30. Langzam L, Koren R, Gal R, et al. Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder: relation to degree of malignancy. Am J Clin Pathol. 2001;116:377-385.
31. van Diest PJ, van Dam P, Henzen-Logmans SC, et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. J Clin Pathol. 1997;50:801-804.
32. Comford PA, Dodson AR, Parsons KF, et al. Heat shock protein (HSP) expression independently predicts clinical outcome in prostate cancer. Cancer Res. 2000;60:7099-7105.
33. Slater SD, Jalleh RP, Gilbertson JA, et al. Expression of heat shock proteins in chronic pancreatitis: protective or pathogenic? Lab Invest. 1997;76:533-545.
34. Richardson KEY, Spooner BS. Mammalian pancreas development: regeneration and differentiation in vitro. Dev Biol. 1977;58:402-420.
35. Teitelman G, Lee J, Reis DJ. Differentiation of prospective mouse pancreatic islet cells during development in vitro and during regeneration. Dev Biol. 1987;120:425-433.
36. Lehv M, Fitzgerald PJ. Pancreatic acinar cell regeneration, IV: regeneration after surgical resection. Am J Pathol. 1968;53:513-535.
37. Pearson KW, Scott D, Torrance B. Effects of partial pancreatectomy in rats, I: pancreatic regeneration. Gastroenterology. 1977;72:469-473.
38. Sommer H. Functional recovery of the exocrine pancreas in rats after partial resection. Eur Surg Res. 1987;19:318-322.
39. Cubilla AL, Fitzgerald PJ. Morphological patterns of primary nonendocrine human pancreas carcinoma. Cancer Res. 1975;35:2234-2248.
40. Kloppel G, Bommer G, Ruckert K, et al. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch A Pathot Anat Histol. 1980;387:221-233.
41. Pour PM, Runge RG, Birt D, et al. Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer. 1981;47:1573-1587.
42. Ruckert K, Pracht B, Kloppel G. Differences in experimental carcinogenesis induced by oral or subcutaneous administration of 2,2-dihydroxydi-N-propylnitrosamine in duct-ligated hamsters. Cancer Res. 1981;41:4715-4719.
43. Caldas C, Hahn SA, Hruban RH, et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res. 1994;54:3568-3573.
44. Real FX. The cell biology of pancreatic cancer. In: Neoptolemos JP, Lemoine NR, eds. Pancreatic Cancer: Molecular and Clinical Advances. Oxford, England: Blackwell Science; 1996:3-17.
45. Jensep HM. The origin and progression of human breast cancer. Am J Obstet Gynecol. 1986;154:1280-1284.
46. Lowenfels A, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med. 1993;328:1433-1437.
47. Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst. 1997;89:442-446.
48. Denham DW, Franz MG, Denham W, et al. Directed antisense therapy confirms the role of protein kinase C-alpha in the tumorigenicity of pancreatic cancer. Surgery. 1998;124:218-223.
49. Detjen KM, Brembeck FH, Welzel M, et al. Activation of protein kinase C alpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest. J Cell Sci. 2000;113:3025-3035.
50. Choi PM, Weinstein B. The modulation of growth by HMBA in PKC overproducing HT29 colon cancer cells. Biochem Biophys Res Commun. 1991;181:809-817.
51. Rusnak JM, Lazo JS. Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells. Exp Cell Res. 1996;224:189-199.
52. Mischak H, Goodnight JA, Kolch W, et al. Overexpression of protein kinase C-delta and epsilon in NIH3T3 cells induces opposite effects of growth, morphology, anchorage dependence and tumourogenicity. J Biol Chem. 1993;268:6090-6096.
53. Watanabe T, Ono Y, Taniyama Y, et al. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc Natl Acad Sci U S A. 1992;89:10159-10163.
54. Mischak H, Pierce JH, Goodnight J, et al. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-betaII,-epsilon, -zeta and -eta. J Biol Chem. 1993;268:20110-20115.
55. Guha S, Rey O, Rozengurt E. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Res. 2002;62:1632-1640.
56. Johannes FJ, Horn J, Link G, et al. Protein kinase C mu downregulation of tumour necrosis factor induced apoptosis correlates with enhanced expression of nuclear factor kappa B dependent protective genes. Eur J Biochem. 1998;257:47-54.
57. Pongracz J, Tuffley W, Johnson GD, et al. Changes in protein kinase C isoenzyme expression associated with apoptosis in U937 myelomonocytic cells. Exp Cell Res. 1995;218:430-438.
58. Trauzold A, Wermann H, Arlt A, et al. CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene. 2001;20:4258-4269.
59. Rosewicz S, Weder M, Kaiser A, et al. Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes. Gut. 1996;39:255-261.
60. Franz MG, Norman JG, Fabri PJ, et al. Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms. Ann Surg Oncol. 1996;3:564-569.
61. Akinaga S, Sugiyama K, Akiyama T. UCN-01 (7-hydroxystaurosporine) and other indolocarbazole compounds: a new generation of anti-cancer agents for the new century? Anticancer Drug Des. 2000;1:43-52.